Eva Jack | Chief Business Officer |
Anna Protopapas | Chief Executive Officer |
Tim Lowinger | Chief Scientific Officer |
David Spellman | Chief Financial Officer |
Michael Ulz | Robert W. Baird |
Jonathan Chang | Leerink Partners |
Boris Peaker | Cowen |
Dilip Joseph | Wedbush |
Debjit Chattopadhyay | H.C. Wainwright |
Good afternoon and welcome to the Mersana Therapeutics’ First Quarter 2018 Conference Call. Currently, all participants are in a listen-only mode. There will be a question-and-answer session at the end of this call. I would now like to turn the call over to the Mersana team. Please proceed.